TITAN PHARMACEUTICALS INC — Director's Dealing 2016

Jan 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP)
CIK: 0000910267
Period of Report: 2016-01-15

Reporting Person: BHONSLE SUNIL (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-15	Common Stock	P	5841	$2.72	Acquired	113815	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	54684	Indirect

Footnotes

F1: The reporting person serves as trustee of the family trust.